Ironwood Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Buy
64,890
+9,700
+18% +$258K 0.76% 39
2025
Q4
$1.37M Buy
55,190
+4,000
+8% +$101K 0.58% 52
2025
Q3
$1.3M Sell
51,190
-200
-0.4% -$4.94K 0.57% 59
2025
Q2
$1.25M Hold
51,390
0.61% 57
2025
Q1
$1.3M Buy
51,390
+12,500
+32% +$327K 0.71% 46
2024
Q4
$1.03M Hold
38,890
0.51% 68
2024
Q3
$1.13M Buy
38,890
+4,120
+12% +$120K 0.55% 61
2024
Q2
$973K Sell
34,770
-20,000
-37% -$551K 0.52% 62
2024
Q1
$1.52M Buy
54,770
+24,155
+79% +$670K 0.74% 40
2023
Q4
$881K Sell
30,615
-700
-2% -$21.2K 0.46% 64
2023
Q3
$1.04M Buy
31,315
+1,200
+4% +$42.4K 0.63% 51
2023
Q2
$1.1M Buy
30,115
+4,970
+20% +$193K 0.64% 49
2023
Q1
$1.03M Buy
25,145
+4,100
+19% +$177K 0.64% 54
2022
Q4
$1.08M Sell
21,045
-700
-3% -$33.6K 0.71% 48
2022
Q3
$952K Sell
21,745
-2,900
-12% -$141K 0.67% 55
2022
Q2
$1.29M Sell
24,645
-6,000
-20% -$306K 0.86% 35
2022
Q1
$1.59M Hold
30,645
0.86% 35
2021
Q4
$1.81M Sell
30,645
-1,200
-4% -$59.5K 0.9% 32
2021
Q3
$1.37M Sell
31,845
-800
-2% -$35.4K 0.71% 42
2021
Q2
$1.28M Buy
32,645
+500
+2% +$19.4K 0.65% 51
2021
Q1
$1.17M Buy
32,145
+14,800
+85% +$525K 0.62% 54
2020
Q4
$638K Buy
17,345
+2,225
+15% +$81.6K 0.37% 91
2020
Q3
$526K Hold
15,120
0.38% 96
2020
Q2
$469K Sell
15,120
-693
-4% -$23.5K 0.37% 104
2020
Q1
$490K Hold
15,813
0.49% 77
2019
Q4
$588K Sell
15,813
-62
-0.4% -$2.21K 0.41% 91
2019
Q3
$541K Hold
15,875
0.41% 91
2019
Q2
$652K Hold
15,875
0.51% 74
2019
Q1
$640K Sell
15,875
-633
-4% -$25.4K 0.52% 69
2018
Q4
$684K Buy
16,508
+121
+0.7% +$5.02K 0.63% 50
2018
Q3
$685K Hold
16,387
0.48% 81
2018
Q2
$564K Hold
16,387
0.4% 97
2018
Q1
$552K Hold
16,387
0.4% 97
2017
Q4
$563K Sell
16,387
-158
-1% -$5.39K 0.4% 92
2017
Q3
$560K Hold
16,545
0.39% 99
2017
Q2
$527K Buy
16,545
+228
+1% +$7.19K 0.38% 97
2017
Q1
$530K Hold
16,317
0.4% 97
2016
Q4
$503K Hold
16,317
0.37% 104
2016
Q3
$524K Sell
16,317
-184
-1% -$6.15K 0.4% 97
2016
Q2
$551K Sell
16,501
-69
-0.4% -$2.2K 0.41% 99
2016
Q1
$466K Hold
16,570
0.31% 113
2015
Q4
$507K Sell
16,570
-105
-0.6% -$3.3K 0.21% 113
2015
Q3
$497K Sell
16,675
-317
-2% -$10.2K 0.18% 117
2015
Q2
$541K Buy
16,992
+2,952
+21% +$96.2K 0.12% 120
2015
Q1
$463K Sell
14,040
-102
-0.7% -$3.24K 0.09% 128
2014
Q4
$418K Hold
14,142
0.08% 135
2014
Q3
$397K Sell
14,142
-100
-0.7% -$2.81K 0.07% 133
2014
Q2
$401K Sell
14,242
-68
-0.5% -$1.94K 0.06% 141
2014
Q1
$436K Buy
14,310
+4,247
+42% +$127K 0.06% 129
2013
Q4
$292K Hold
10,063
0.04% 146
2013
Q3
$274K Hold
10,063
0.04% 143
2013
Q2
$267K Buy
+10,063
New +$278K 0.05% 146

Other funds holding PFE

Ironwood Investment Management's PFE Position: Q1 2026 in Review

Ironwood Investment Management increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $258K and bringing the position to 64,890 shares worth $1.82M. The position accounts for 0.76% of the portfolio, ranked #39.

Ironwood Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ironwood Investment Management held 64,890 shares of Pfizer worth $1.82M as of Q1 2026.
  • Ironwood Investment Management bought 9,700 Pfizer shares in Q1 2026, an estimated $258K.
  • Pfizer made up 0.76% of Ironwood Investment Management's portfolio in Q1 2026, its #39 holding.
  • Ironwood Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.